Be SMART NIS, Moderate to Servere Asthma Patient Observation

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00514787
First received: August 9, 2007
Last updated: March 26, 2009
Last verified: March 2009
  Purpose

Screen for moderate to severe asthma patients with suboptimal asthma control (as defined by GINA-Guidelines). Document current asthma control status. Re-evaluate asthma therapy and document new therapy if applicable.


Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Be SMART NIS, Moderate to Servere Asthma Patient Observation

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Estimated Enrollment: 900
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Moderate to severe asthma with suboptimal control

Exclusion Criteria:

  • Intermittent or mild asthma, patient with good asthma control
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00514787

Locations
Austria
Research Site
Vienna, Austria
Sponsors and Collaborators
AstraZeneca
Investigators
Study Chair: Wolfgang Pohl, PHD Executive Board OGP (Austria Society of Pneumology
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00514787     History of Changes
Other Study ID Numbers: NIS-RAT-SYM-2007/1
Study First Received: August 9, 2007
Last Updated: March 26, 2009
Health Authority: Austria: Agency for Health and Food Safety

Keywords provided by AstraZeneca:
Asthma
NIS

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 23, 2014